Oxford Immunotec (OXFD) Enters MOU with GC MS to Market the T-SPOT Discovery SARS-CoV-2 Kit, for the Measurement of the T Cell Immune Response to SARS-CoV-2 Infection, in South
Go back to Oxford Immunotec (OXFD) Enters MOU with GC MS to Market the T-SPOT Discovery SARS-CoV-2 Kit, for the Measurement of the T Cell Immune Response to SARS-CoV-2 Infection, in South| OXFORD (NASDAQ: OXFD) | Delayed: 21.99 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.99 | 52 Week High | $14.73 | |||
| Open | $133.34 | 52 Week Low | $7.73 | |||
| Day High | $21.99 | P/E | N/A | |||
| Day Low | $21.99 | EPS | $0.00 | |||
| Volume | 82,369 | |||||
